Fennec Pharmaceuticals Inc.
FENC
We, our, ours, us, Fennec, or the Company, when used herein, refers to Fennec Pharmaceuticals Inc., a British Columbia corporation, and its wholly-owned subsidiary, Fennec Pharmaceuticals, Inc., a Delaware corporation. These include statements regarding our expectations, beliefs, plans or objectives for future operations and anticipated results of operations.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$66M
▼ -6.1% YoY
Net Income (TTM)
$2M
▼ -2134.2% YoY
Op. Margin
5.60%
▼ -19.5pp YoY
ROIC
7.13%
▼ -26.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▼ -146.2% YoY
Op. Cash Flow (TTM)
$3M
▼ -146.2% YoY
Net Debt
-$49M
Net Cash Position
Cash & Equiv.
$49M
Continue Research
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with FENC
Held by ETFs
FENC is in 5 US ETFs. The largest of them, with FENC's weight in each:
Fennec Pharmaceuticals (FENC) in four numbers
Questions about Fennec Pharmaceuticals
Is Fennec Pharmaceuticals (FENC) overvalued?
At $10.90, Fennec Pharmaceuticals' price is 1879% above the $0.55 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 566.74 times earnings and 122.21 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Fennec Pharmaceuticals' fair value?
Intrinsiqq's calculator puts Fennec Pharmaceuticals' fair value at $0.55 a share. It grows earnings per share 5% a year for 5 years, applies an exit P/E of 12.1, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.41. Every input can be changed on the Intrinsic Value tab.
Is Fennec Pharmaceuticals a high-quality business?
Fennec Pharmaceuticals scores 50 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from SEC filings. Its best check is revenue growth at 156.4%, and its weakest is return on capital at 7.1%. The Quality tab shows every check against its target.
Does Fennec Pharmaceuticals (FENC) pay a dividend?
No. Fennec Pharmaceuticals (FENC) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 10 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 12 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in FENC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing FENC
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.